Anti-neoplastic properties of hydralazine in prostate cancer

Prostate cancer (PCa) is a major cause of cancer-related morbidity and mortality worldwide. Although early disease is often efficiently managed therapeutically, available options for advanced disease are mostly ineffective. Aberrant DNA methylation associated with gene-silencing of cancer-related ge...

ver descrição completa

Detalhes bibliográficos
Autor principal: Pinho dos Santos Graça, Maria Inês (author)
Outros Autores: Sousa, Elsa Joana (author), Costa-Pinheiro, Pedro (author), Quintela Vieira, Ana Filipa (author), Torres-Ferreira, Jorge (author), Martins, Maria Gabriela (author), Henrique, Rui (author), Jeronimo, Carmen (author)
Formato: article
Idioma:eng
Publicado em: 2015
Assuntos:
Prostate Cancer
Hydralazine
DNA methyltransferases
Androgen Receptor
Texto completo:http://hdl.handle.net/10400.22/6046
País:Portugal
Oai:oai:recipp.ipp.pt:10400.22/6046

Texto Completo

http://hdl.handle.net/10400.22/6046

Registos relacionados